914 research outputs found
Anterior subtemporal approach for posteriorly projecting posterior communicating artery aneurysms
The original publication is available at www.springerlink.com.ArticleNeurosurgical Review. 30(3): 203-207 (2007)journal articl
Use of a micromanipulator system (NeuRobot) in endoscopic neurosurgery
NeuRobot, a micromanipulator system with a rigid neuroendoscope and three micromanipulators, was developed for less invasive and telecontrolled neurosurgery. This system can be used to perform sophisticated surgical procedures through a small, 10-mm-diameter, window. The present study was performed to evaluate the feasibility of using NeuRobot in neuroendoscopy. Four different intraventricular neurosurgical procedures were simulated in three fixed cadaver heads using NeuRobot: (1) fenestration of the floor of the third ventricle; (2) fenestration of the septum pellucidum; (3) biopsy of the thalamus; and (4) biopsy of the choroid plexus of the lateral ventricle. Each procedure required less than 2 min, and all procedures were performed accurately. After these surgical simulations, a third ventriculostomy was carried out safely and adequately in a patient with obstructive hydrocephalus due to a midbrain venous angioma. Our results confirmed that NeuRobot is applicable to lesions in which conventional endoscopic neurosurgery is indicated. Furthermore, NeuRobot can perform more complex surgical procedures than a conventional neuroendoscope because of its maneuverability and stability. NeuRobot will become a useful neurosurgical tool for dealing with lesions that are difficult to treat by conventional neuroendoscopic surgery.ArticleJOURNAL OF CLINICAL NEUROSCIENCE. 19(11):1553-1557 (2012)journal articl
P16-55 LB. The role of CD4+ CD25+ regulatory T cells in the control of IL-10 mediated T cell impairment in chronic HIV Infection
Contributions of the direct supply of belowground seagrass detritus and trapping of suspended organic matter to the sedimentary organic carbon stock in seagrass meadows
Carbon captured by marine living organisms is called blue carbon, and
seagrass meadows are a dominant blue carbon sink. However, our knowledge of
how seagrass increases sedimentary organic carbon (OC) stocks is limited. We
investigated two pathways of OC accumulation: trapping of organic matter in
the water column and the direct supply of belowground seagrass detritus. We
developed a new type of box corer to facilitate the retrieval of intact cores
that preserve the structures of both sediments (including coarse sediments
and dead plant structures) and live seagrasses. We measured seagrass density,
total OC mass (OCtotal) (live seagrass OC biomass
(OCbio) + sedimentary OC mass (OCsed)), and the
stable carbon isotope ratio (δ13C) of OCsed and its
potential OC sources at Thalassia hemprichii dominated back-reef and
Enhalus acoroides dominated estuarine sites in the tropical
Indo-Pacific region. At points with vegetation, OCbio accounted
for 25 % and OCsed for 75 % of OCtotal; this
contribution of OCbio to OCtotal is higher than in
globally compiled data. Belowground detritus accounted for  ∼  90 %
of the OC mass of dead plant structures (> 2 mm in size)
(OCdead). At the back-reef site, belowground seagrass biomass,
OCdead, and δ13C of OCsed (δ13Csed) were positively correlated with OCsed,
indicating that the direct supply of belowground seagrass detritus is a major
mechanism of OCsed accumulation. At the estuarine site,
aboveground seagrass biomass was positively correlated with OCsed
but δ13Csed did not correlate with OCsed,
indicating that trapping of suspended OC by seagrass leaves is a major
mechanism of OCsed accumulation there. We inferred that the
relative importance of these two pathways may depend on the supply
(productivity) of belowground biomass. Our results indicate that belowground
biomass productivity of seagrass meadows, in addition to their aboveground
morphological complexity, is an important factor controlling their OC stock.
Consideration of this factor will improve global blue carbon estimates.</p
Use of a micromanipulator system (NeuRobot) in endoscopic neurosurgery
NeuRobot, a micromanipulator system with a rigid neuroendoscope and three micromanipulators, was developed for less invasive and telecontrolled neurosurgery. This system can be used to perform sophisticated surgical procedures through a small, 10-mm-diameter, window. The present study was performed to evaluate the feasibility of using NeuRobot in neuroendoscopy. Four different intraventricular neurosurgical procedures were simulated in three fixed cadaver heads using NeuRobot: (1) fenestration of the floor of the third ventricle; (2) fenestration of the septum pellucidum; (3) biopsy of the thalamus; and (4) biopsy of the choroid plexus of the lateral ventricle. Each procedure required less than 2 min, and all procedures were performed accurately. After these surgical simulations, a third ventriculostomy was carried out safely and adequately in a patient with obstructive hydrocephalus due to a midbrain venous angioma. Our results confirmed that NeuRobot is applicable to lesions in which conventional endoscopic neurosurgery is indicated. Furthermore, NeuRobot can perform more complex surgical procedures than a conventional neuroendoscope because of its maneuverability and stability. NeuRobot will become a useful neurosurgical tool for dealing with lesions that are difficult to treat by conventional neuroendoscopic surgery.ArticleJOURNAL OF CLINICAL NEUROSCIENCE. 19(11):1553-1557 (2012)journal articl
Glycan shifting on hepatitis C virus (HCV) E2 glycoprotein is a mechanism for escape from broadly neutralizing antibodies
Hepatitis C virus (HCV) infection is a major cause of liver disease and hepatocellular carcinoma. Glycan shielding has been proposed to be a mechanism by which HCV masks broadly neutralizing epitopes on its viral glycoproteins. However, the role of altered glycosylation in HCV resistance to broadly neutralizing antibodies is not fully understood. Here, we have generated potent HCV neutralizing antibodies hu5B3.v3 and MRCT10.v362 that, similar to the previously described AP33 and HCV1, bind to a highly conserved linear epitope on E2. We utilize a combination of in vitro resistance selections using the cell culture infectious HCV and structural analyses to identify mechanisms of HCV resistance to hu5B3.v3 and MRCT10.v362. Ultra deep sequencing from in vitro HCV resistance selection studies identified resistance mutations at asparagine N417 (N417S, N417T and N417G) as early as 5 days post treatment. Comparison of the glycosylation status of soluble versions of the E2 glycoprotein containing the respective resistance mutations revealed a glycosylation shift from N417 to N415 in the N417S and N417T E2 proteins. The N417G E2 variant was glycosylated neither at residue 415 nor at residue 417 and remained sensitive to MRCT10.v362. Structural analyses of the E2 epitope bound to hu5B3.v3 Fab and MRCT10.v362 Fab using X-ray crystallography confirmed that residue N415 is buried within the antibody–peptide interface. Thus, in addition to previously described mutations at N415 that abrogate the β-hairpin structure of this E2 linear epitope, we identify a second escape mechanism, termed glycan shifting, that decreases the efficacy of broadly neutralizing HCV antibodies
Organic solid-state distributed feedback dye laser with a nonmorphological modification grating
This article may be downloaded for personal use only. Any other use requires prior permission of the author and the American Institute of Physics. The following article appeared in APPLIED PHYSICS LETTERS. 77(17):2641-2643 (2000) and may be found at https://doi.org/10.1063/1.1320034 .ArticleAPPLIED PHYSICS LETTERS. 77(17):2641-2643 (2000)journal articl
Serum high-density lipoprotein cholesterol level and lifestyle habits among Japanese junior high school students
- …